Literature DB >> 3455657

Periorbital and orbital cellulitis.

V Israele, J D Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3455657     DOI： 10.1097/00006454-198704000-00012

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  9 in total

1.  Etiology, Diagnosis, and Treatment of Orbital Infections.

Authors:  Gary Schwartz
Journal:  Curr Infect Dis Rep       Date:  2002-06       Impact factor: 3.725

2.  Pediatric emergencies.

Authors:  J S Surpure
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

3.  Strategies for the initial management of acute preseptal and orbital cellulitis.

Authors:  D B Jones; P G Steinkuller
Journal:  Trans Am Ophthalmol Soc       Date:  1988

4.  Management of preseptal and orbital cellulitis.

Authors:  Seongmu Lee; Michael T Yen
Journal:  Saudi J Ophthalmol       Date:  2010-12-10

5.  Radiographic Findings and Clinical Correlates in Pediatric Periorbital Infections.

Authors:  Jonathan M Grischkan; Charles A Elmaraghy; Matthew R Garrett; Boris Karanfilov; Kris R Jatana
Journal:  Int J Otorhinolaryngol       Date:  2015-01

6.  Presentation and management of pediatric orbital cellulitis.

Authors:  Sergio Fanella; Alex Singer; Joanne Embree
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

Review 7.  COVID-19 and Mucormycosis Coinfection: How Challenging It Is.

Authors:  Niranjan Nayak; Erum Khan; Debadatta Panigrahi
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-04-07       Impact factor: 2.585

8.  [Orbital cellulitis: prospective study about 75 cases].

Authors:  Sarah Belghmaidi; Btissam Belhoucha; Ibtissam Hajji; Khaoula Hssaine; Youssef Rochdi; Hassan Nouri; Lahcen Aderdour; Abdelaziz Raji; Abdeljalil Moutaouakil
Journal:  Pan Afr Med J       Date:  2015-12-10

Review 9.  Acute rhinosinusitis in children.

Authors:  Cheryl C Nocon; Fuad M Baroody
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.